» Articles » PMID: 38529036

Clinical Presentation and Diagnosis of Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia: a Literature Analysis of Case Studies

Overview
Journal Front Neurol
Specialty Neurology
Date 2024 Mar 26
PMID 38529036
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Because adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is a rare, rapidly progressive, debilitating, and ultimately fatal neurodegenerative disease, a rapid and accurate diagnosis is critical. This analysis examined the frequency of initial misdiagnosis of ALSP via comprehensive review of peer-reviewed published cases.

Methods: Data were extracted from a MEDLINE search via PubMed (January 1, 1980, through March 22, 2022) from eligible published case reports/series for patients with an ALSP diagnosis that had been confirmed by testing for the colony-stimulating factor-1 receptor gene () mutation. Patient demographics, clinical symptoms, brain imaging, and initial diagnosis data were summarized descriptively. Categorical data for patient demographics, symptoms, and brain imaging were stratified by initial diagnosis category to test for differences in initial diagnosis based on each variable.

Results: Data were extracted from a cohort of 291 patients with ALSP from 93 published case reports and case series. Mean (standard deviation) age of symptom onset was 43.2 (11.6) years. A family history of ALSP was observed in 59.1% of patients. Cognitive impairment (47.1%) and behavioral and psychiatric abnormalities (26.8%) were the most frequently reported initial symptoms. Of 291 total cases, an accurate initial diagnosis of ALSP was made in 72 cases (24.7%) and the most frequent initial misdiagnosis categories were frontotemporal dementia (28 [9.6%]) and multiple sclerosis (21 [7.2%]). Of the 219 cases (75.3%) that were initially mis- or undiagnosed, 206 cases (94.1%) were later confirmed as ALSP by immunohistology, imaging, and/or genetic testing; for the remaining 13 cases, no final diagnosis was reported. Initial diagnosis category varied based on age, family history, geographic region, mode of inheritance, and presenting symptoms of pyramidal or extrapyramidal motor dysfunction, behavioral and psychiatric abnormalities, cognitive impairment, and speech difficulty. Brain imaging abnormalities were common, and initial diagnosis category was significantly associated with white matter hyperintensities, white matter calcifications, and ventricular enlargement.

Discussion: In this literature analysis, ALSP was frequently misdiagnosed. Improving awareness of this condition and distinguishing it from other conditions with overlapping presenting symptoms is important for timely management of a rapidly progressive disease such as ALSP.

Citing Articles

Rescue of in vitro models of CSF1R-related adult-onset leukodystrophy by iluzanebart: mechanisms and therapeutic implications of TREM2 agonism.

Larson K, Gergits F, Renoux A, Weisman E, Dejanovic B, Huang L J Neuroinflammation. 2025; 22(1):26.

PMID: 39891235 PMC: 11783791. DOI: 10.1186/s12974-025-03346-1.


Mapping the journey of patients and care partners living with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: developing a framework for improvements in care.

Rutherford H, Rush B, Smith A, Sullivan E, Martinez-Rubio C, Toumadj A Neurodegener Dis Manag. 2024; 14(5):161-172.

PMID: 39363647 PMC: 11524202. DOI: 10.1080/17582024.2024.2404378.


Deciphering glial contributions to CSF1R-related disorder via single-nuclear transcriptomic profiling: a case study.

Pan J, Fores-Martos J, Nouh C, Jensen T, Vallejo K, Cayrol R Acta Neuropathol Commun. 2024; 12(1):139.

PMID: 39217398 PMC: 11365264. DOI: 10.1186/s40478-024-01853-5.


Novel variants in CSF1R associated with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP).

Schmitz A, Raju J, Kohler W, Klebe S, Cheheb K, Reschke F J Neurol. 2024; 271(9):6025-6037.

PMID: 39031193 PMC: 11377666. DOI: 10.1007/s00415-024-12557-0.


Identification and characterization of a novel intronic splicing mutation in CSF1R-related leukoencephalopathy.

Han Y, Han J, Li Z, Chen S, Liu J, Zhou R CNS Neurosci Ther. 2024; 30(6):e14815.

PMID: 38922778 PMC: 11194178. DOI: 10.1111/cns.14815.

References
1.
Kawakami I, Iseki E, Kasanuki K, Minegishi M, Sato K, Hino H . A family with hereditary diffuse leukoencephalopathy with spheroids caused by a novel c.2442+2T>C mutation in the CSF1R gene. J Neurol Sci. 2016; 367:349-55. DOI: 10.1016/j.jns.2016.06.013. View

2.
Lynch D, de Paiva A, Zhang W, Bugiardini E, Freua F, Lucato L . Clinical and genetic characterization of leukoencephalopathies in adults. Brain. 2017; 140(5):1204-1211. PMC: 5405235. DOI: 10.1093/brain/awx045. View

3.
Okamoto M, Takeshita J, Takahashi K, Tanaka A, Yoshida K, Kuriyama M . Retraction:Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: A case presented brain calcification and corpus callosum atrophy from over 10 years before the onset of dementia. Rinsho Shinkeigaku. 2017; 57(9):521-526. DOI: 10.5692/clinicalneurol.cn-001072. View

4.
Lopes C, Duarte S, Santos E, Reis C, Pinto M . Intrafamilial heterogeneity in hereditary diffuse leukoencephalopathy with axonal spheroids. Neurol Clin Pract. 2020; 9(6):500-502. PMC: 6927449. DOI: 10.1212/CPJ.0000000000000647. View

5.
Sundal C, Lash J, Aasly J, Oygarden S, Roeber S, Kretzschman H . Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): a misdiagnosed disease entity. J Neurol Sci. 2011; 314(1-2):130-7. PMC: 3275663. DOI: 10.1016/j.jns.2011.10.006. View